Diseases & Disorders
(G30Z)
990 on File
SOUTHEAST CLINICAL ONCOLOGY RESEARCH CONSORTIUM INC
Financial strength (30%)
45/100
Reliability (20%)
55/100
Effectiveness (25%)
74/100
Impact (25%)
No data yet
CharityAI™ Score
Not yet evaluated
Financial Overview — FY 2025
$2.9M
Total Revenue
$2.9M
Total Expenses
$408K
Net Assets
7
Employees
Revenue Sources
Expense Breakdown
Program Expense Ratio
98.7%
Fundraising Efficiency
N/A
Operating Reserve
1.67x
Liability-to-Asset
73.0%
Revenue Diversification
89.0%
Executive Compensation
$60K
Compared with Peers
FY 2025
Compared with 264 similar organizations
(United States, Diseases & Disorders, $1M–$10M in expenses), FY 2025.
This organization
Middle half of peers (P25–P75)
Peer median
| Ratio | This org | Peer median | Position (P10 → P90) | |
|---|---|---|---|---|
|
Program expense ratio
Program expenses / total expenses
· higher is better
|
98.7% | 83.2% |
P10P90
|
Top quarter |
|
Admin expense ratio
Management and general / total expenses
· lower is better
|
1.3% | 11.0% |
P10P90
|
Top quarter |
|
Fundraising expense ratio
Fundraising expenses / total expenses
· lower is better
|
0.0% | 2.5% |
P10P90
|
Top quarter |
|
Operating reserve
Months of expenses covered by net assets
· higher is better
|
1.7 mo | 12.5 mo |
P10P90
|
Bottom quarter |
|
Liabilities to assets
Total liabilities / total assets
· lower is better
|
73.0% | 12.5% |
P10P90
|
Bottom quarter |
|
Revenue concentration
Share of revenue from the largest source
· lower is better
|
89.0% | 87.6% |
P10P90
|
Below median |
|
Surplus margin
Surplus as a share of revenue
|
-1.1% | 4.1% |
P10P90
|
Financial History
| Year | Revenue | Expenses | Net Assets | Program % | Staff |
|---|---|---|---|---|---|
| 2025 | $2.9M | $2.9M | $408K | 98.7% | 7 |
| 2023 | $3.6M | $3.6M | $442K | 99.0% | 8 |
| 2022 | $3.1M | $3.1M | $514K | 98.4% | 11 |
| 2021 | $3.9M | $3.8M | N/A | — | 8 |
Donor Reviews
Write a ReviewNo reviews yet
Be the first to share your experience with this organization.